[Oral antidiabetics. Dose, plasma concentration and effect].
D000092:Acetohexamide / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002271:Carbutamide / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D002747:Chlorpropamide / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D003981:Diazoxide / Q000494:pharmacology; D004336:Drug Antagonism; D004357:Drug Synergism; D005934:Glucagon / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D007545:Isoproterenol / Q000494:pharmacology; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D013449:Sulfonamides / Q000494:pharmacology; D013453:Sulfonylurea Compounds / Q000378:metabolism; D013806:Theophylline / Q000494:pharmacology; D014044:Tolbutamide / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D013449:Sulfonamides; D013453:Sulfonylurea Compounds; D005934:Glucagon; D014044:Tolbutamide; D013806:Theophylline; D000242:Cyclic AMP; D002271:Carbutamide; D005947:Glucose; D007545:Isoproterenol; D003981:Diazoxide; D000092:Acetohexamide; D002747:Chlorpropamide